Drugs / Islet cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02402439 | Mar 2016 → Apr 2024 | type 1 diabetes mellitus | Andrew Posselt | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Islet cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02402439 ↗ |
| Modality | Cell therapy | “Pancreatic islet transplantation offers a minimally invasive approach to restore normoglycemia” NCT02402439 ↗ |
| Route | Other | “transplanting islets into a new transplant site in the stomach (gastrointestinal submucosa)” NCT02402439 ↗ |